XENE News and Press, Xenon Pharmaceuticals Inc.

2026-03-11 02:36:39 ET Xenon Pharmaceuticals ( XENE ) announced pricing of its upsized underwritten public offering of 10.53M common shares and pre-funded warrants for up to 877,194 common shares.... Read the full article on Seeking Alpha For further deta...

VANCOUVER, British Columbia and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today ...

2026-03-09 17:03:22 ET Yatin Suneja from Guggenheim issued a price target of $90.00 for XENE on 2026-03-09 18:47:00. The adjusted price target was set to $90.00. At the time of the announcement, XENE was trading at $62.76. The overall price target consensus is at $61.83 ...

2026-03-09 17:03:21 ET from Robert W. Baird issued a price target of $97.00 for XENE on 2026-03-09 16:20:00. The adjusted price target was set to $97.00. At the time of the announcement, XENE was trading at $62.76. The overall price target consensus is at $61.83 with hig...

2026-03-09 17:03:21 ET from Morgan Stanley issued a price target of $97.00 for XENE on 2026-03-09 16:20:00. The adjusted price target was set to $97.00. At the time of the announcement, XENE was trading at $62.76. The overall price target consensus is at $61.83 with high...

A look at the top 10 most actives in the United States Autozi Internet Technology (Global) Ltd. (AZI) rose 146.4% to $0.65 on volume of 528,049,630 shares Elong Power Holding Limited (ELPW) rose 6.7% to $0.048 on volume of 380,279,563 shares EON Resources Inc. Class A (EONR) rose 19.4% to $...

2026-03-09 16:05:49 ET More on Xenon Pharma Xenon Pharmaceuticals Inc. (XENE) Discusses Positive Top Line Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures Transcript Xenon Pharmaceuticals Inc. (XENE) Discusses Positive Top Line Results from Phase 3 X...

VANCOUVER, British Columbia and BOSTON, MA, March 09, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, to...

2026-03-09 14:39:42 ET More on Xenon Pharma Xenon Pharmaceuticals Inc. (XENE) Discusses Positive Top Line Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures Transcript Xenon Pharmaceuticals Inc. (XENE) Discusses Positive Top Line Results from Phase 3 X...

2026-03-09 14:17:59 ET Xenon Pharmaceuticals Inc. (XENE) Discusses Positive Top Line Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures March 9, 2026 8:00 AM EDT... Read the full article on Seeking Alpha For further details see: Xenon Pharmaceuticals I...